Target intelligence / Profile preview

SMT3 suppressor of mif two 3 homolog 1 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

SMT3 suppressor of mif two 3 homolog 1 pseudogene (ENSG00000213655) is a human pseudogene corresponding to the yeast *SMT3* gene, and is annotated as a nonfunctional copy of the gene encoding a small ubiquitin-like modifier (SUMO1). Pseudogenes do not produce functional proteins and are not therapeutic targets; confusion may arise due to the existence of active SUMO1, SUMO2, and SUMO3 genes, which play important roles in post-translational modification of proteins by sumoylation, impacting nuclear transport, DNA repair, mitosis, and more. This pseudogene is not implicated in disease, pharmacology, or as a biomarker. ENSG00000213655 is explicitly annotated as a pseudogene in all prominent genetic databases. The related functional gene is **SUMO1** (Small Ubiquitin-Like Modifier 1), which is involved in sumoylation of proteins in various cellular processes, but this record refers only to the pseudogene, which does not encode any functional protein product. There is potential for confusion because the nomenclature and homology relate to important protein modifiers (SUMO family), but this locus is not functionally active. There are no drugs, actionable mechanisms, or biomarker roles associated with this pseudogene, and it should not be considered a therapeutic or pharmacological target.

Other names
AC010493.1SUMO1 pseudogeneSUMO1P1

Beyond the preview

Go deeper on SMT3 suppressor of mif two 3 homolog 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMT3 suppressor of mif two 3 homolog 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call